Innovation continues to advance technologies in coronary artery disease (CAD)—beyond simply managing CAD to repairing, restoring and healing vasculature. Abbott technologies enable physicians to approach each patient with sophisticated insights from imaging and physiology assessments to identify the presence or absence of ischemia, and interventional therapies with proven safety that have become the industry’s gold standard.
As a global leader in cardiology, Abbott is dedicated to supporting healthcare professionals no matter how simple or complex their CAD cases may be. We’re all striving toward the same goal: offering optimal therapies, ensuring patient safety and improving their health.
Optical coherence tomography (OCT) provides the intravascular imaging guidance that physicians increasingly turn to during PCI to guide decision-making. Angiography’s two-dimensional (2D) imaging, while beneficial, has inherent limitations. But with three-dimensional (3-D) OCT imaging it’s possible to quantify plaque morphology, as well as calcium location and severity.1 3-D OCT imaging allows the quantification of plaque morphology, plus assessment of coronary calcium location and its severity.2 OCT offers angiographic co-registration to guide precise stent placement and review post-deployment results to optimize stent expansion.2 Discover the benefits of Abbott’s OCT imaging today.
Physiological measurements such as fractional flow reserve (FFR) and resting full-cycle ratio (RFR) can be used to evaluate the functional significance of coronary stenosis.3,4 Beyond the visibility of angiography, index of microcirculatory resistance (IMR) and coronary flow reserve (CFR) can be used to diagnose coronary microvascular dysfunction.5,6 A comprehensive physiology assessment can improve PCI outcomes and patients quality of life.5,7-8
The post-PCI decision about dual antiplatelet therapy (DAPT) duration must be individualized for each patient. However, Abbott’s XIENCE™ Stents provide the only 28-day DAPT labeling option for patients at high bleeding risk.9 With the increasing numbers of complex cases, safety data on Abbott stents—for both short-term and long-term DAPT duration—can offer assurance to healthcare professionals focused on patient safety.10
MAT-2202837 v1.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0
